Doctors didn't disclose spine product cancer risk in journal
Doctors paid millions of dollars by Medtronic failed to identify a significant cancer risk with the company’s spine surgery product in a 2009 paper about results of a large clinical trial. (MILWAUKEE JOURNAL SENTINEL, 10/24)
To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.